Prism Medico and Pharmacy Statistics
Total Valuation
BOM:512217 has a market cap or net worth of INR 102.53 million. The enterprise value is 101.88 million.
| Market Cap | 102.53M |
| Enterprise Value | 101.88M |
Important Dates
The next estimated earnings date is Wednesday, February 11, 2026.
| Earnings Date | Feb 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BOM:512217 has 6.06 million shares outstanding.
| Current Share Class | 6.06M |
| Shares Outstanding | 6.06M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 30.03% |
| Owned by Institutions (%) | 2.37% |
| Float | 2.73M |
Valuation Ratios
The trailing PE ratio is 16.96.
| PE Ratio | 16.96 |
| Forward PE | n/a |
| PS Ratio | 4.32 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 16.86 |
| EV / Sales | 4.29 |
| EV / EBITDA | 17.61 |
| EV / EBIT | 17.72 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 239.50 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 7.65% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 6.41% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -249,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -12.22% in the last 52 weeks. The beta is 0.39, so BOM:512217's price volatility has been lower than the market average.
| Beta (5Y) | 0.39 |
| 52-Week Price Change | -12.22% |
| 50-Day Moving Average | 18.61 |
| 200-Day Moving Average | 16.99 |
| Relative Strength Index (RSI) | 38.17 |
| Average Volume (20 Days) | 3,824 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:512217 had revenue of INR 23.72 million and earned 6.04 million in profits. Earnings per share was 0.01.
| Revenue | 23.72M |
| Gross Profit | 8.98M |
| Operating Income | 5.75M |
| Pretax Income | 5.80M |
| Net Income | 6.04M |
| EBITDA | 5.79M |
| EBIT | 5.75M |
| Earnings Per Share (EPS) | 0.01 |
Balance Sheet
| Cash & Cash Equivalents | n/a |
| Total Debt | n/a |
| Net Cash | n/a |
| Net Cash Per Share | n/a |
| Equity (Book Value) | n/a |
| Book Value Per Share | n/a |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 37.84%, with operating and profit margins of 24.23% and 25.48%.
| Gross Margin | 37.84% |
| Operating Margin | 24.23% |
| Pretax Margin | 24.43% |
| Profit Margin | 25.48% |
| EBITDA Margin | 24.38% |
| EBIT Margin | 24.23% |
| FCF Margin | n/a |
Dividends & Yields
BOM:512217 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 5.89% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |